Tuesday, Nov. 10, 2026
Time: 10 a.m. to 4:30 p.m.
This forum will discuss genetic testing reference materials availability and needs (for test validation, quality control, and proficiency testing). Speakers will present a variety of current reference material development projects for molecular testing of inherited and somatic genetic disorders, and infectious disease followed by group discussion. We also want to hear your thoughts and facilitate active discussions to formulate a fuller understanding of your reference material needs for particular disorders, specific molecular methods, or specific genes. These may include inherited disorders, molecular oncology, infectious diseases and others.
Please note that the AMP Reference Material Forum is a noncommercial event. Please contact us for information regarding exhibiting, advertising and other commercial opportunities with AMP.
How do I register?
When you register for the annual meeting, make sure you select the forum add-on ticket to register for this event. If you do not plan to attend the meeting but wish to attend forum, please contact meetings@amp.org. On-site registration will be accommodated based on availability.
The registration fee is $15.
Since this forum is an ancillary event, speakers and attendees are responsible for their own travel expenses. AMP does not provide support for participant expenses related to the forum.
Speakers will present a variety of current reference material development projects for molecular testing of inherited and acquired somatic genetic disorders, followed by group discussion.
We also want to facilitate active discussions to formulate a fuller understanding of the community's reference material needs for particular disorders, specific molecular methods, or specific genes. These may include inherited disorders, molecular oncology, infectious diseases and others.
If you would like to be a speaker, please email the forum coordinator, Lisa V. Kalman of the Centers for Disease Control and Prevention. Send a brief description of your presentation for consideration by Aug. 14.